Your dashboard is green. The suite has passed, coverage looks healthy and leadership assumes the release is safe. But a passing test suite may be misleading. Even with a green dashboard, it's unclear ...

To our knowledge, this study is the first to apply deep learning models that can, beyond diagnosis, identify molecular subtypes and predict outcomes in a single brain tumour entity (meningioma) using ...